litlas
Log inCreate account

Scott A. Summers

Active 1996–2025

90
Papers
18,553
Citations
57
h-index
87
i10-index

Citations

Citations per year for Scott A. Summers1986: 1 citations1996: 1 citations1997: 17 citations1998: 56 citations1999: 120 citations2000: 96 citations2001: 138 citations2002: 111 citations2003: 93 citations2004: 98 citations2005: 93 citations2006: 76 citations2007: 142 citations2008: 184 citations2009: 176 citations2010: 150 citations2011: 194 citations2012: 267 citations2013: 261 citations2014: 224 citations2015: 212 citations2016: 260 citations2017: 245 citations2018: 244 citations2019: 765 citations2020: 826 citations2021: 836 citations2022: 664 citations2023: 521 citations2024: 805 citations2025: 334 citations2026: 3 citations1987–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,318 citing papers, 29.8% of this breakdownChina: 914 citing papers, 11.7% of this breakdownUnited Kingdom: 402 citing papers, 5.2% of this breakdownGermany: 348 citing papers, 4.5% of this breakdownCanada: 296 citing papers, 3.8% of this breakdownAustralia: 279 citing papers, 3.6% of this breakdownItaly: 269 citing papers, 3.4% of this breakdownFrance: 238 citing papers, 3.1% of this breakdownJapan: 223 citing papers, 2.9% of this breakdownSpain: 204 citing papers, 2.6% of this breakdownNetherlands: 171 citing papers, 2.2% of this breakdownSouth Korea: 168 citing papers, 2.2% of this breakdown
0%29.8%Other 25%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology45.1%
  • Medicine44.4%
  • Neuroscience3.5%
  • Immunology and Microbiology1.8%
  • Nursing1.7%
  • Agricultural and Biological Sciences1.4%
  • Other2.1%

Topics

  • Adipose Tissue and Metabolism7.3%
  • Sphingolipid Metabolism and Signaling5.6%
  • Adipokines, Inflammation, and Metabolic Diseases4.6%
  • Metabolism, Diabetes, and Cancer4%
  • Liver Disease Diagnosis and Treatment3.7%
  • Pancreatic function and diabetes2.7%
  • Other72.1%

Coauthors

All papers

Open in search
  1. Ceramides and other sphingolipids as drivers of cardiovascular disease

    Authors: Ran Hee Choi, Sean M. Tatum, J. David Symons, Scott A. Summers, William L. Holland - Nature Reviews Cardiology 2021 cited by 387

  2. Ceramides in Metabolism: Key Lipotoxic Players

    Authors: Bhagirath Chaurasia, Scott A. Summers - Annual Review of Physiology 2020 cited by 327

  3. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis

    Authors: Bhagirath Chaurasia, Trevor S. Tippetts, Rafael Mayoral, Jinqi Liu, Ying Li, Liping Wang, Joseph L. Wilkerson, Carol R. Sweeney, Renato Felipe Pereira, Dóris Hissako Sumida, J. Alan Maschek, James E. Cox, Vincent Kaddai, Graeme I. Lancaster, Monowarul Mobin Siddique, Annelise M. Poss, Mackenzie Pearson, Santhosh Satapati, Heather Zhou, David G. McLaren, Stephen F. Previs, Ying Chen, Ying Qian, Aleksandr Petrov, Margaret Wu, Xiaolan Shen, Jun Yao, Christian Nunes da Silva, Andrew D. Howard, Liangsu Wang, Mark D. Erion, Jared Rutter, William L. Holland, David E. Kelley, Scott A. Summers - Science 2019 cited by 450

  4. Metabolic Messengers: ceramides

    Authors: Scott A. Summers, Bhagirath Chaurasia, William L. Holland - Nature Metabolism 2019 cited by 307

  5. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin

    Authors: William L. Holland, Russell Miller, Zhao V. Wang, Kai Sun, Brian M. Barth, Hai H. Bui, Kathryn E. Davis, Benjamin T. Bikman, Nils Halberg, Joseph M. Rutkowski, Mark Wade, Vincent M Tenorio, Ming‐Shang Kuo, Joseph T. Brozinick, Bei B. Zhang, Morris J. Birnbaum, Scott A. Summers, Philipp E. Scherer - Nature Medicine 2010 cited by 879

  6. Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance

    Authors: William L. Holland, Joseph T. Brozinick, Liping Wang, Eric D. Hawkins, Katherine M. Sargent, Yanqi Liu, Krishna K. Narra, Kyle L. Hoehn, Trina A. Knotts, Angela M. Siesky, Don H. Nelson, Sotirios K. Karathanasis, Greg K. Fontenot, Morris J. Birnbaum, Scott A. Summers - Cell Metabolism 2007 cited by 1,213

  7. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in mice

    Authors: William L. Holland, Benjamin T. Bikman, Liping Wang, Yuguang Guan, Katherine M. Sargent, Sarada Bulchand, Trina A. Knotts, Guanghou Shui, Deborah J. Clegg, Markus R. Wenk, Michael J. Pagliassotti, Philipp E. Scherer, Scott A. Summers - Journal of Clinical Investigation 2011 cited by 681

  8. Ceramides – Lipotoxic Inducers of Metabolic Disorders

    Authors: Bhagirath Chaurasia, Scott A. Summers - Trends in Endocrinology and Metabolism 2015 cited by 605

  9. A Ceramide-Centric View of Insulin Resistance

    Authors: Jose A. Chavez, Scott A. Summers - Cell Metabolism 2012 cited by 595

  10. Ceramides in insulin resistance and lipotoxicity

    Authors: Scott A. Summers - Progress in Lipid Research 2005 cited by 843

  11. Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease

    Authors: Annelise M. Poss, J. Alan Maschek, James E. Cox, Benedikt J. Hauner, Paul N. Hopkins, Steven C. Hunt, William L. Holland, Scott A. Summers, Mary C. Playdon - Journal of Clinical Investigation 2019 cited by 244

  12. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders

    Authors: Peter J. Meikle, Scott A. Summers - Nature Reviews Endocrinology 2016 cited by 428

  13. Metabolic dysfunction and obesity‐related cancer: Beyond obesity and metabolic syndrome

    Authors: Prasoona Karra, Maci Winn, Svenja Pauleck, Alicja Bulsiewicz‐Jacobsen, Lacie Peterson, Adriana M. Coletta, Jennifer A. Doherty, Cornelia M. Ulrich, Scott A. Summers, Marc J. Gunter, Sheetal Hardikar, Mary C. Playdon - Obesity 2022 cited by 163

  14. Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy

    Authors: Rohit A. Sinha, Seo-Hee You, Jin Zhou, Monowarul Mobin Siddique, Boon‐Huat Bay, Xuguang Zhu, Martin L. Privalsky, Sheue-yann Cheng, Robert D. Stevens, Scott A. Summers, Christopher B. Newgard, Mitchell A. Lazar, Paul M. Yen - Journal of Clinical Investigation 2012 cited by 305

  15. Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism

    Authors: William L. Holland, Scott A. Summers - Endocrine Reviews 2008 cited by 579

  16. CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance

    Authors: Suryaprakash Raichur, Siew Tein Wang, Puck Wee Chan, Ying Li, Jianhong Ching, Bhagirath Chaurasia, Shaillay Kumar Dogra, Miina K. Öhman, Kosuke Takeda, Shigeki Sugii, Yael Pewzner‐Jung, Anthony H. Futerman, Scott A. Summers - Cell Metabolism 2014 cited by 453

  17. Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism

    Authors: Bhagirath Chaurasia, Vincent Kaddai, Graeme I. Lancaster, Darren C. Henstridge, Sandhya Sriram, Dwight L.A. Galam, Venkatesh Gopalan, K. N. Bhanu Prakash, S. Sendhil Velan, Sarada Bulchand, Teh Jing Tsong, Mei Wang, Monowarul Mobin Siddique, Yuguang Guan, Kristmundur Sigmundsson, Natalie A. Mellet, Jacquelyn M. Weir, Peter J. Meikle, M. Shabeer Yassin, Asim Shabbir, James A. Shayman, Yoshio Hirabayashi, Sue-Anne Toh Ee Shiow, Shigeki Sugii, Scott A. Summers - Cell Metabolism 2016 cited by 240

  18. Reign in the membrane: How common lipids govern mitochondrial function

    Authors: Katsuhiko Funai, Scott A. Summers, Jared Rutter - Current Opinion in Cell Biology 2020 cited by 96

  19. Regulation of Insulin Action by Ceramide

    Authors: Suzanne Stratford, Kyle L. Hoehn, Feng Liu, Scott A. Summers - Journal of Biological Chemistry 2004 cited by 392

  20. Ceramides as modulators of cellular and whole-body metabolism

    Authors: Benjamin T. Bikman, Scott A. Summers - Journal of Clinical Investigation 2011 cited by 412

  21. Could Ceramides Become the New Cholesterol?

    Authors: Scott A. Summers - Cell Metabolism 2018 cited by 181

  22. Adipocyte Ceramides—The Nexus of Inflammation and Metabolic Disease

    Authors: Bhagirath Chaurasia, Chad Lamar Talbot, Scott A. Summers - Frontiers in Immunology 2020 cited by 93

  23. Regulation of Insulin-Stimulated Glucose Transporter GLUT4 Translocation and Akt Kinase Activity by Ceramide

    Authors: Scott A. Summers, Luis A. Garza, Honglin Zhou, Morris J. Birnbaum - Molecular and Cellular Biology 1998 cited by 470

  24. Ceramide Mediates Vascular Dysfunction in Diet-Induced Obesity by PP2A-Mediated Dephosphorylation of the eNOS-Akt Complex

    Authors: Quan‐Jiang Zhang, William L. Holland, Lloyd Wilson, Jason M. Tanner, Devin Kearns, Judd Cahoon, Dix Pettey, Jason T. Losee, Bradlee Duncan, Derrick C. Gale, Christopher Kowalski, Nicholas Deeter, Alexandrea Nichols, Michole Deesing, Colton Arrant, Ting Ruan, Christoph Boehme, Dane R. McCamey, Janvida Rou, Kapil Ambal, Krishna K. Narra, Scott A. Summers, E. Dale Abel, J. David Symons - Diabetes 2012 cited by 232